Although mutations within the TP53 gene are considered the most frequent [31], [32] and one of the earliest genetic alterations [33], [34] in the carcinogenesis of SCCHN their prognostic value is still a matter of debate. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.